| Cyclin-dependent kinase inhibitors in brain cancer: Current state and future directions V Juric, B Murphy Cancer Drug Resistance 3 (1), 48, 2020 | 38 | 2020 |
| Marizomib sensitizes primary glioma cells to apoptosis induced by a latest-generation TRAIL receptor agonist C Boccellato, E Kolbe, N Peters, V Juric, G Fullstone, M Verreault, ... Cell Death & Disease 12 (7), 647, 2021 | 19 | 2021 |
| Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP-and Bcl-2 antagonism FA Lincoln, D Imig, C Boccellato, V Juric, J Noonan, RE Kontermann, ... Cell death & disease 9 (11), 1112, 2018 | 19 | 2018 |
| Intracellular trafficking and functional monitoring of miRNA delivery in glioblastoma using lipopolyplexes and the miRNA-ON RILES reporter system V Simion, E Henriet, V Juric, R Aquino, C Loussouarn, Y Laurent, F Martin, ... Journal of controlled release 327, 429-443, 2020 | 17 | 2020 |
| Implementing patient-derived xenografts to assess the effectiveness of cyclin-dependent kinase inhibitors in glioblastoma JJ Noonan, M Jarzabek, FA Lincoln, BL Cavanagh, AR Pariag, V Juric, ... Cancers 11 (12), 2005, 2019 | 9 | 2019 |
| Transcriptional CDK inhibitors, CYC065 and THZ1 promote Bim-dependent apoptosis in primary and recurrent GBM through cell cycle arrest and Mcl-1 downregulation V Juric, L Hudson, J Fay, CE Richards, H Jahns, M Verreault, F Bielle, ... Cell Death & Disease 12 (8), 763, 2021 | 8 | 2021 |
| Transcriptional CDK inhibitors CYC065 and THZ1 induce apoptosis in glioma stem cells derived from recurrent GBM V Juric, H Düssmann, MLM Lamfers, JHM Prehn, M Rehm, BM Murphy Cells 10 (5), 1182, 2021 | 5 | 2021 |
| Phenotypic selection through cell death: stochastic modelling of o-6-methylguanine-dna methyltransferase dynamics A Lasri, V Juric, M Verreault, F Bielle, A Idbaih, A Kel, B Murphy, ... Royal Society open science 7 (7), 191243, 2020 | 3 | 2020 |
| Targeting MCL-1 Dependence in GBM Using Transcriptional CDK Inhibitors CYC065 and THZ1 V Juric Royal College of Surgeons in Ireland, 2022 | | 2022 |
| P13. 11 Transcriptional CDK inhibitors, CYC065 and THZ1 promote apoptosis in preclinical models of primary and recurrent GBM tumour cells and glioma stem cells V Juric, H Duessmann, H Jahns, M Verreault, A Idbaih, ML Lamfers, ... Neuro-Oncology 23 (Supplement_2), ii34-ii35, 2021 | | 2021 |
| Adhezijska svojstva probiotičkih sojeva iz rodova Lactobacillus i Bifidobacterium V Jurić University of Zagreb. Faculty of Food Technology and Biotechnology …, 2014 | | 2014 |
